Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | triprolidine | 5282443 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | triprolidine | 5282443 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | triprolidine | 5282443 | drug-path |
Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | triprolidine | 5282443 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | triprolidine | 5282443 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | triprolidine | 5282443 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | Prestwick-674 | None | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | Prestwick-674 | None | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | Prestwick-674 | None | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | Prestwick-674 | None | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | Prestwick-674 | None | drug-path |
Asthma | R-HSA-444620 | map05310 | Prestwick-674 | None | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | Prestwick-674 | None | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | Prestwick-674 | None | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | Prestwick-674 | None | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | Prestwick-674 | None | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | Prestwick-674 | None | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | Prestwick-674 | None | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | SR-95639A | 195164 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | SR-95639A | 195164 | drug-path |